UPDATE 1-Chelsea Therapeutics hypotension drug rejected by U.S. FDA
March 28, 2012 at 19:38 PM EDT
March 28 (Reuters) - Chelsea Therapeutics International Ltd said U.S. health regulators rejected its hypotension capsule Northera and sought an additional trial to support the efficacy of the drug.
